Evidence map›Paper›PMID 35945422›Full record

ArticleScientific reports2022

Matrix stiffness and architecture drive fibro-adipogenic progenitors' activation into myofibroblasts.

Taryn Loomis, Lin-Ya Hu, Ross P Wohlgemuth, Rosemary R Chellakudam, Pooja D Muralidharan, Lucas R Smith

Open access · greenAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 0 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Food science of animal resources · 2025
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Taryn LoomisUniversity of California, Davis, CA, USA.
Lin-Ya HuUniversity of California, Davis, CA, USA.
Ross P WohlgemuthUniversity of California, Davis, CA, USA.
Rosemary R ChellakudamUniversity of California, Davis, CA, USA.
Pooja D MuralidharanUniversity of California, Davis, CA, USA.
Lucas R SmithUniversity of California, Davis, CA, USA. lucsmith@ucdavis.edu.
University of Nevada, Las Vegas · US

Funding

Interdependency of fibroadipogenic progenitors and extracellular matrix that drive skeletal muscle fibrosisR01AR079545 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LUCAS R SMITH · 2022 to 2026
$2.5M
The role of collagen organization in determination of fibrotic muscle function and regenerationR00AR067867 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SMITH, LUCAS R · 2018 to 2020
$741k
NIAMS NIH HHS R00 AR067867NIAMS NIH HHS R00AR067867NIAMS NIH HHS R01 AR079545
6 · The paper itself

Abstract

Fibro-adipogenic progenitors (FAPs) are essential in supporting regeneration in skeletal muscle, but in muscle pathologies FAPs the are main source of excess extracellular matrix (ECM) resulting in fibrosis. Fibrotic ECM has altered mechanical and architectural properties, but the feedback onto FAPs of stiffness or ECM properties is largely unknown. In this study, FAPs' sensitivity to their ECM substrate was assessed using collagen coated polyacrylamide to control substrate stiffness and collagen hydrogels to engineer concentration, crosslinking, fibril size, and alignment. FAPs on substrates of fibrotic stiffnesses had increased myofibroblast activation, depicted by αSMA expression, compared to substrates mimicking healthy muscle, which correlated strongly YAP nuclear localization. Surprisingly, fibrosis associated collagen crosslinking and larger fibril size inhibited myofibroblast activation, which was independent of YAP localization. Additionally, collagen crosslinking and larger fibril diameters were associated with decreased remodeling of the collagenous substrate as measured by second harmonic generation imaging. Inhibition of YAP activity through verteporfin reduced myofibroblast activation on stiff substrates but not substrates with altered architecture. This study is the first to demonstrate that fibrotic muscle stiffness can elicit FAP activation to myofibroblasts through YAP signaling. However, fibrotic collagen architecture actually inhibits myofibroblast activation through a YAP independent mechanism. These data expand knowledge of FAPs sensitivity to ECM and illuminate targets to block FAP's from driving progression of muscle fibrosis.

Indexed as

AdipogenesisMyofibroblastsCell DifferentiationCollagenExtracellular MatrixFibrosisHumansMuscle, SkeletalCollagen

Identifiers

PMID35945422
PMCPMC9363488
OpenAlexW35945422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.